<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-10-07" version="192">
<accession>Q14814</accession>
<accession>D3DVC0</accession>
<accession>Q14815</accession>
<accession>Q5T9U5</accession>
<accession>Q5T9U6</accession>
<name>MEF2D_HUMAN</name>
<protein>
<recommendedName>
<fullName>Myocyte-specific enhancer factor 2D</fullName>
</recommendedName>
</protein>
<gene>
<name type="primary">MEF2D</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Development" volume="118" first="1095" last="1106">
<title>A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage.</title>
<authorList>
<person name="Breitbart R.E."/>
<person name="Liang C.-S."/>
<person name="Smoot L.B."/>
<person name="Laheru D.A."/>
<person name="Mahdavi V."/>
<person name="Nadal-Ginard B."/>
</authorList>
<dbReference type="PubMed" id="8269842"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS MEF2D00; MEF2D0B; MEF2DA'0; MEF2DA'B; MEF2DA0 AND MEF2DAB)</scope>
<source>
<tissue>Myocardium</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS MEF2DA0 AND MEF2DAB)</scope>
<source>
<tissue>Eye</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="21" last="30">
<title>Regulation of the MEF2 family of transcription factors by p38.</title>
<authorList>
<person name="Zhao M."/>
<person name="New L."/>
<person name="Kravchenko V.V."/>
<person name="Kato Y."/>
<person name="Gram H."/>
<person name="di Padova F."/>
<person name="Olson E.N."/>
<person name="Ulevitch R.J."/>
<person name="Han J.-D."/>
</authorList>
<dbReference type="PubMed" id="9858528"/>
<dbReference type="DOI" id="10.1128/mcb.19.1.21"/>
</citation>
<scope>HETERODIMERIZATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="7816" last="7827">
<title>HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor.</title>
<authorList>
<person name="Wang A.H."/>
<person name="Bertos N.R."/>
<person name="Vezmar M."/>
<person name="Pelletier N."/>
<person name="Crosato M."/>
<person name="Heng H.H."/>
<person name="Th'ng J."/>
<person name="Han J."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="10523670"/>
<dbReference type="DOI" id="10.1128/mcb.19.11.7816"/>
</citation>
<scope>INTERACTION WITH HDAC4</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="18534" last="18540">
<title>Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.</title>
<authorList>
<person name="Kato Y."/>
<person name="Zhao M."/>
<person name="Morikawa A."/>
<person name="Sugiyama T."/>
<person name="Chakravortty D."/>
<person name="Koide N."/>
<person name="Yoshida T."/>
<person name="Tapping R.I."/>
<person name="Yang Y."/>
<person name="Yokochi T."/>
<person name="Lee J.D."/>
</authorList>
<dbReference type="PubMed" id="10849446"/>
<dbReference type="DOI" id="10.1074/jbc.m001573200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-180</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-180 AND SER-437</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="197" last="209">
<title>Ca(2+)-dependent gene expression mediated by MEF2 transcription factors.</title>
<authorList>
<person name="Blaeser F."/>
<person name="Ho N."/>
<person name="Prywes R."/>
<person name="Chatila T.A."/>
</authorList>
<dbReference type="PubMed" id="10617605"/>
<dbReference type="DOI" id="10.1074/jbc.275.1.197"/>
</citation>
<scope>PHOSPHORYLATION BY CAMK4</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="3974" last="3979">
<title>Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis.</title>
<authorList>
<person name="Okamoto S."/>
<person name="Li Z."/>
<person name="Ju C."/>
<person name="Scholzke M.N."/>
<person name="Mathews E."/>
<person name="Cui J."/>
<person name="Salvesen G.S."/>
<person name="Bossy-Wetzel E."/>
<person name="Lipton S.A."/>
</authorList>
<dbReference type="PubMed" id="11904443"/>
<dbReference type="DOI" id="10.1073/pnas.022036399"/>
</citation>
<scope>PROTEOLYTIC PROCESSING AT ASP-288</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-288</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Neuron" volume="38" first="33" last="46">
<title>Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis.</title>
<authorList>
<person name="Gong X."/>
<person name="Tang X."/>
<person name="Wiedmann M."/>
<person name="Wang X."/>
<person name="Peng J."/>
<person name="Zheng D."/>
<person name="Blair L.A.C."/>
<person name="Marshall J."/>
<person name="Mao Z."/>
</authorList>
<dbReference type="PubMed" id="12691662"/>
<dbReference type="DOI" id="10.1016/s0896-6273(03)00191-0"/>
</citation>
<scope>PHOSPHORYLATION AT SER-444</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-444</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28749" last="28760">
<title>Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.</title>
<authorList>
<person name="Zhu B."/>
<person name="Ramachandran B."/>
<person name="Gulick T."/>
</authorList>
<dbReference type="PubMed" id="15834131"/>
<dbReference type="DOI" id="10.1074/jbc.m502491200"/>
</citation>
<scope>FUNCTION OF BETA DOMAIN</scope>
<scope>MUTAGENESIS OF THR-286; GLU-287; ASP-288; HIS-289 AND ASP-291</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="J. Neurosci." volume="25" first="4823" last="4834">
<title>Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2.</title>
<authorList>
<person name="Tang X."/>
<person name="Wang X."/>
<person name="Gong X."/>
<person name="Tong M."/>
<person name="Park D."/>
<person name="Xia Z."/>
<person name="Mao Z."/>
</authorList>
<dbReference type="PubMed" id="15888658"/>
<dbReference type="DOI" id="10.1523/jneurosci.1331-05.2005"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>PHOSPHORYLATION AT SER-444</scope>
<scope>MUTAGENESIS OF SER-444</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="2273" last="2287">
<title>Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.</title>
<authorList>
<person name="Gregoire S."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="15743823"/>
<dbReference type="DOI" id="10.1128/mcb.25.6.2273-2287.2005"/>
</citation>
<scope>SUMOYLATION AT LYS-439</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="8456" last="8464">
<title>Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.</title>
<authorList>
<person name="Zhao X."/>
<person name="Sternsdorf T."/>
<person name="Bolger T.A."/>
<person name="Evans R.M."/>
<person name="Yao T.-P."/>
</authorList>
<dbReference type="PubMed" id="16166628"/>
<dbReference type="DOI" id="10.1128/mcb.25.19.8456-8464.2005"/>
</citation>
<scope>SUMOYLATION AT LYS-439</scope>
<scope>ACETYLATION AT LYS-439</scope>
<scope>DEACETYLATION</scope>
<scope>MUTAGENESIS OF ILE-438 AND LYS-439</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="3575" last="3582">
<title>Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.</title>
<authorList>
<person name="Ma K."/>
<person name="Chan J.K."/>
<person name="Zhu G."/>
<person name="Wu Z."/>
</authorList>
<dbReference type="PubMed" id="15831463"/>
<dbReference type="DOI" id="10.1128/mcb.25.9.3575-3582.2005"/>
</citation>
<scope>ACETYLATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="4423" last="4433">
<title>Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation.</title>
<authorList>
<person name="Gregoire S."/>
<person name="Tremblay A.M."/>
<person name="Xiao L."/>
<person name="Yang Q."/>
<person name="Ma K."/>
<person name="Nie J."/>
<person name="Mao Z."/>
<person name="Wu Z."/>
<person name="Giguere V."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="16356933"/>
<dbReference type="DOI" id="10.1074/jbc.m509471200"/>
</citation>
<scope>SUMOYLATION AT LYS-439</scope>
<scope>PHOSPHORYLATION AT SER-444</scope>
<scope>MUTAGENESIS OF LYS-439 AND SER-444</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-251</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-245</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="40830" last="40837">
<title>HDAC3 is negatively regulated by the nuclear protein DBC1.</title>
<authorList>
<person name="Chini C.C."/>
<person name="Escande C."/>
<person name="Nin V."/>
<person name="Chini E.N."/>
</authorList>
<dbReference type="PubMed" id="21030595"/>
<dbReference type="DOI" id="10.1074/jbc.m110.153270"/>
</citation>
<scope>INTERACTION WITH CCAR2 AND HDAC3</scope>
<scope>ACETYLATION</scope>
<scope>DEACETYLATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121; SER-180; SER-231 AND SER-251</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-251</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text evidence="8 15 16 17 18 20">Transcriptional activator which binds specifically to the MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific, growth factor- and stress-induced genes. Mediates cellular functions not only in skeletal and cardiac muscle development, but also in neuronal differentiation and survival. Plays diverse roles in the control of cell growth, survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription. Plays a critical role in the regulation of neuronal apoptosis (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="9 10 13 24">Interacts with MYOG (By similarity). Forms a complex with class II HDACs in undifferentiating cells. On myogenic differentiation, HDACs are released into the cytoplasm allowing MEF2s to interact with other proteins for activation. Interacts with HDAC4 (in undifferentiating cells); the interaction translocates MEF2D to nuclear dots. Forms a heterodimer with MEF2A. Interacts with MAPK7; the interaction phosphorylates but does not activate MEF2D (By similarity). Interacts with CCAR2 and HDAC3.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="12 17 18">Nucleus</location>
</subcellularLocation>
<text>Translocated by HDAC4 to nuclear dots.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q14814-1</id>
<name>MEF2DAB</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q14814-2</id>
<name>MEF2DA'B</name>
<sequence type="described" ref="VSP_006250"/>
</isoform>
<isoform>
<id>Q14814-3</id>
<name>MEF2D0B</name>
<sequence type="described" ref="VSP_006251"/>
</isoform>
<isoform>
<id>Q14814-4</id>
<name>MEF2DA0</name>
<sequence type="described" ref="VSP_006252"/>
</isoform>
<isoform>
<id>Q14814-5</id>
<name>MEF2DA'0</name>
<sequence type="described" ref="VSP_006250 VSP_006252"/>
</isoform>
<isoform>
<id>Q14814-6</id>
<name>MEF2D00</name>
<sequence type="described" ref="VSP_006251 VSP_006252"/>
</isoform>
</comment>
<comment type="developmental stage">
<text>Present in myotubes and also in undifferentiated myoblasts.</text>
</comment>
<comment type="domain">
<text>The beta domain, missing in a number of isoforms, is required for enhancement of transcriptional activity.</text>
</comment>
<comment type="PTM">
<text evidence="14 15 16 17 18 21 22 23">Phosphorylated on Ser-444 by CDK5 is required for Lys-439 sumoylation and inhibits transcriptional activity. In neurons, enhanced CDK5 activity induced by neurotoxins promotes caspase 3-mediated cleavage leading to neuron apoptosis. Phosphorylation on Ser-180 can be enhanced by EGF. Phosphorylated and activated by CaMK4.</text>
</comment>
<comment type="PTM">
<text evidence="19 22 24">Acetylated on Lys-439 by CREBBP. Acetylated by EP300. Deacetylated by SIRT1 and HDAC3.</text>
</comment>
<comment type="PTM">
<text evidence="18 22 23">Sumoylated on Lys-439 with SUMO2 but not SUMO1; which inhibits transcriptional activity and myogenic activity. Desumoylated by SENP3.</text>
</comment>
<comment type="PTM">
<text evidence="8">Proteolytically cleaved in cerebellar granule neurons on several sites by caspase 7 following neurotoxicity. Preferentially cleaves the CDK5-mediated hyperphosphorylated form which leads to neuron apoptosis and transcriptional inactivation (By similarity).</text>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the MEF2 family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MEF2DID43636ch1q22.html"/>
</comment>
<dbReference type="EMBL" id="L16794">
<property type="protein sequence ID" value="AAA93194.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L16795">
<property type="protein sequence ID" value="AAA59579.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL139412">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW52948.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW52952.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC040949">
<property type="protein sequence ID" value="AAH40949.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC054520">
<property type="protein sequence ID" value="AAH54520.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1143.1">
<molecule id="Q14814-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS60304.1">
<molecule id="Q14814-4"/>
</dbReference>
<dbReference type="PIR" id="I53124">
<property type="entry name" value="I53124"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001258558.1">
<molecule id="Q14814-4"/>
<property type="nucleotide sequence ID" value="NM_001271629.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005911.1">
<molecule id="Q14814-1"/>
<property type="nucleotide sequence ID" value="NM_005920.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005245226.1">
<molecule id="Q14814-1"/>
<property type="nucleotide sequence ID" value="XM_005245169.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005245227.1">
<molecule id="Q14814-1"/>
<property type="nucleotide sequence ID" value="XM_005245170.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006711393.1">
<molecule id="Q14814-1"/>
<property type="nucleotide sequence ID" value="XM_006711330.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006711395.1">
<molecule id="Q14814-2"/>
<property type="nucleotide sequence ID" value="XM_006711332.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006711396.1">
<molecule id="Q14814-4"/>
<property type="nucleotide sequence ID" value="XM_006711333.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006711397.1">
<molecule id="Q14814-5"/>
<property type="nucleotide sequence ID" value="XM_006711334.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011507871.1">
<molecule id="Q14814-1"/>
<property type="nucleotide sequence ID" value="XM_011509569.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016856803.1">
<molecule id="Q14814-4"/>
<property type="nucleotide sequence ID" value="XM_017001314.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016856804.1">
<molecule id="Q14814-4"/>
<property type="nucleotide sequence ID" value="XM_017001315.1"/>
</dbReference>
<dbReference type="SMR" id="Q14814"/>
<dbReference type="BioGRID" id="110373">
<property type="interactions" value="41"/>
</dbReference>
<dbReference type="ELM" id="Q14814"/>
<dbReference type="IntAct" id="Q14814">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="MINT" id="Q14814"/>
<dbReference type="STRING" id="9606.ENSP00000271555"/>
<dbReference type="BindingDB" id="Q14814"/>
<dbReference type="GlyConnect" id="2862">
<property type="glycosylation" value="1 O-Linked glycan (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="Q14814">
<property type="glycosylation" value="5 sites, 1 O-linked glycan (5 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q14814"/>
<dbReference type="PhosphoSitePlus" id="Q14814"/>
<dbReference type="BioMuta" id="MEF2D"/>
<dbReference type="DMDM" id="2500876"/>
<dbReference type="EPD" id="Q14814"/>
<dbReference type="jPOST" id="Q14814"/>
<dbReference type="MassIVE" id="Q14814"/>
<dbReference type="MaxQB" id="Q14814"/>
<dbReference type="PaxDb" id="Q14814"/>
<dbReference type="PeptideAtlas" id="Q14814"/>
<dbReference type="PRIDE" id="Q14814"/>
<dbReference type="ProteomicsDB" id="60190">
<molecule id="Q14814-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60191">
<molecule id="Q14814-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60192">
<molecule id="Q14814-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60193">
<molecule id="Q14814-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60194">
<molecule id="Q14814-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60195">
<molecule id="Q14814-6"/>
</dbReference>
<dbReference type="Antibodypedia" id="1437">
<property type="antibodies" value="458 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000348159">
<molecule id="Q14814-1"/>
<property type="protein sequence ID" value="ENSP00000271555"/>
<property type="gene ID" value="ENSG00000116604"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000360595">
<molecule id="Q14814-4"/>
<property type="protein sequence ID" value="ENSP00000353803"/>
<property type="gene ID" value="ENSG00000116604"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000464356">
<molecule id="Q14814-5"/>
<property type="protein sequence ID" value="ENSP00000476788"/>
<property type="gene ID" value="ENSG00000116604"/>
</dbReference>
<dbReference type="GeneID" id="4209"/>
<dbReference type="KEGG" id="hsa:4209"/>
<dbReference type="UCSC" id="uc001fpb.5">
<molecule id="Q14814-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4209"/>
<dbReference type="DisGeNET" id="4209"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000116604.17"/>
<dbReference type="GeneCards" id="MEF2D"/>
<dbReference type="HGNC" id="HGNC:6997">
<property type="gene designation" value="MEF2D"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000116604">
<property type="expression patterns" value="Tissue enhanced (skeletal)"/>
</dbReference>
<dbReference type="MIM" id="600663">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14814"/>
<dbReference type="OpenTargets" id="ENSG00000116604"/>
<dbReference type="PharmGKB" id="PA30735"/>
<dbReference type="eggNOG" id="KOG0014">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159463"/>
<dbReference type="HOGENOM" id="CLU_022902_4_0_1"/>
<dbReference type="InParanoid" id="Q14814"/>
<dbReference type="KO" id="K09262"/>
<dbReference type="OMA" id="NADIIEX"/>
<dbReference type="OrthoDB" id="729387at2759"/>
<dbReference type="PhylomeDB" id="Q14814"/>
<dbReference type="TreeFam" id="TF314067"/>
<dbReference type="PathwayCommons" id="Q14814"/>
<dbReference type="Reactome" id="R-HSA-2151201">
<property type="pathway name" value="Transcriptional activation of mitochondrial biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-525793">
<property type="pathway name" value="Myogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9031628">
<property type="pathway name" value="NGF-stimulated transcription"/>
</dbReference>
<dbReference type="SignaLink" id="Q14814"/>
<dbReference type="SIGNOR" id="Q14814"/>
<dbReference type="BioGRID-ORCS" id="4209">
<property type="hits" value="33 hits in 893 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MEF2D">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="MEF2D"/>
<dbReference type="GenomeRNAi" id="4209"/>
<dbReference type="Pharos" id="Q14814">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14814"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q14814">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000116604">
<property type="expression patterns" value="Expressed in gastrocnemius and 233 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q14814">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14814">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033613">
<property type="term" value="F:activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007512">
<property type="term" value="P:adult heart development"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002062">
<property type="term" value="P:chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001958">
<property type="term" value="P:endochondral ossification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007517">
<property type="term" value="P:muscle organ development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001649">
<property type="term" value="P:osteoblast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904707">
<property type="term" value="P:positive regulation of vascular associated smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035914">
<property type="term" value="P:skeletal muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00265">
<property type="entry name" value="MADS_MEF2_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.1810.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR022102">
<property type="entry name" value="HJURP_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR033896">
<property type="entry name" value="MADS_MEF2-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR002100">
<property type="entry name" value="TF_MADSbox"/>
</dbReference>
<dbReference type="InterPro" id="IPR036879">
<property type="entry name" value="TF_MADSbox_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF12347">
<property type="entry name" value="HJURP_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00319">
<property type="entry name" value="SRF-TF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00404">
<property type="entry name" value="MADSDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00432">
<property type="entry name" value="MADS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55455">
<property type="entry name" value="SSF55455"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00350">
<property type="entry name" value="MADS_BOX_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50066">
<property type="entry name" value="MADS_BOX_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Myocyte-specific enhancer factor 2D" id="PRO_0000199435">
<location>
<begin position="1"/>
<end position="521"/>
</location>
</feature>
<feature type="domain" description="MADS-box" evidence="12">
<location>
<begin position="3"/>
<end position="57"/>
</location>
</feature>
<feature type="DNA-binding region" description="Mef2-type" evidence="11">
<location>
<begin position="58"/>
<end position="86"/>
</location>
</feature>
<feature type="region of interest" description="Beta domain">
<location>
<begin position="286"/>
<end position="292"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg/Lys-rich (basic)">
<location>
<begin position="3"/>
<end position="31"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="252"/>
<end position="255"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln/Pro-rich">
<location>
<begin position="365"/>
<end position="404"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="451"/>
<end position="456"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="27">
<location>
<begin position="288"/>
<end position="289"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="106"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="110"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="6 14">
<location>
<position position="121"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK7" evidence="1 3 5 6 15">
<location>
<position position="180"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="10">
<location>
<position position="190"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 6">
<location>
<position position="231"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="245"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 6 7">
<location>
<position position="251"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="22">
<location>
<position position="439"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17 21 23">
<location>
<position position="444"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="439"/>
</location>
</feature>
<feature type="splice variant" description="In isoform MEF2D0B and isoform MEF2D00." id="VSP_006251" evidence="26">
<location>
<begin position="87"/>
<end position="132"/>
</location>
</feature>
<feature type="splice variant" description="In isoform MEF2DA'B and isoform MEF2DA'0." id="VSP_006250" evidence="26">
<original>TLRKKGFNGCDSPEPDGEDSLEQSPLLEDKYRRASEELDGLFRRYG</original>
<variation>ALHKKHRECESPEVDEVFALTPQTEEKYKKIDEEFDKMMQSYRLA</variation>
<location>
<begin position="87"/>
<end position="132"/>
</location>
</feature>
<feature type="splice variant" description="In isoform MEF2DA0, isoform MEF2DA'0 and isoform MEF2D00." id="VSP_006252" evidence="25 26">
<location>
<begin position="286"/>
<end position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2274315." id="VAR_022155">
<original>P</original>
<variation>S</variation>
<location>
<position position="434"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes MAPK7- and EGF-mediated transcriptional activation." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="mutagenesis site" description="Same transcriptional activity as for isoforms with beta domain." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes transcriptional activity; when associated with N-288 and N-291." evidence="20">
<original>E</original>
<variation>Q</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes cleavage by caspase 7." evidence="16 20">
<original>D</original>
<variation>A</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes transcriptional activity; when associated with Q-287 and N-291." evidence="16 20">
<original>D</original>
<variation>N</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="mutagenesis site" description="Same transcriptional activity as for isoforms with beta domain." evidence="20">
<original>H</original>
<variation>A</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes transcriptional activity; when associated with Q-287 and N-288." evidence="20">
<original>D</original>
<variation>N</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on MAPK7- or EGF-mediated transcriptional activity." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes K-439 sumoylation." evidence="22">
<original>I</original>
<variation>A</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes sumoylation and acetylation." evidence="22 23">
<original>K</original>
<variation>R</variation>
<location>
<position position="439"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes K-439 sumoylation. Reduced neurotoxin-induced apoptosis of neuronal cells. More resistant to degradation." evidence="17 21 23">
<original>S</original>
<variation>A</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on K-439 sumoylation." evidence="17 21 23">
<original>S</original>
<variation>E</variation>
<location>
<position position="444"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O89038"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q63943"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00251"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10523670"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10617605"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10849446"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11904443"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12691662"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15743823"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15831463"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15834131"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15888658"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16166628"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16356933"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21030595"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8269842"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<sequence length="521" mass="55938" checksum="5C9790AD598619BA" modified="1997-11-01" version="1">MGRKKIQIQRITDERNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNHSNKLFQYASTDMDKVLLKYTEYNEPHESRTNADIIETLRKKGFNGCDSPEPDGEDSLEQSPLLEDKYRRASEELDGLFRRYGSTVPAPNFAMPVTVPVSNQSSLQFSNPSGSLVTPSLVTSSLTDPRLLSPQQPALQRNSVSPGLPQRPASAGAMLGGDLNSANGACPSPVGNGYVSARASPGLLPVANGNSLNKVIPAKSPPPPTHSTQLGAPSRKPDLRVITSQAGKGLMHHLTEDHLDLNNAQRLGVSQSTHSLTTPVVSVATPSLLSQGLPFSSMPTAYNTDYQLTSAELSSLPAFSSPGGLSLGNVTAWQQPQQPQQPQQPQPPQQQPPQPQQPQPQQPQQPQQPPQQQSHLVPVSLSNLIPGSPLPHVGAALTVTTHPHISIKSEPVSPSRERSPAPPPPAVFPAARPEPGDGLSSPAGGSYETGDRDDGRGDFGPTLGLLRPAPEPEAEGSAVKRMRLDTWTLK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

